SB 1083 Maryland Senate · 2018 Regular Session

Public Health - Prescription Drug Monitoring Program - Revisions

Bill status passed both 4 of 5 stages cleared

Introduction

Feb 2018

Committee Review

Apr 2018

Senate Passage

Apr 2018

House of Delegates Passage

Apr 2018

Governor

Introduced Feb 12, 2018 Last action Apr 9, 2018

Floor votes · Senate Apr 3, 2018 · House of Delegates Apr 7, 2018

How they voted

39–0

Passed · 1 other

Total votes 40

Apr 3, 2018

D Democratic28

27 Yea 1

96% Yea

R Republican12

12 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Apr 9, 2018

Upper · Passed

Conference Committee Appointed

upper

Apr 9, 2018

Introduced

Senate Refuses to Concur - House Amendments

upper

Apr 7, 2018

Lower · Passed

Third Reading Passed with Amendments (135-0)

lower

Apr 7, 2018

Lower · Passed

Motion Rules Suspended two readings same day (Delegate Bromwell) Adopted (132-1)

lower

Apr 7, 2018

Lower · Passed

Favorable with Amendments {986881/1 Report Adopted

lower

Apr 7, 2018

Lower · Passed

Favorable with Amendments Report by Health and Government Operations

lower

Apr 4, 2018

Committee

Rereferred to Health and Government Operations

lower

Apr 3, 2018

Committee

First Reading House Rules and Executive Nominations

lower

Apr 3, 2018

Upper · Passed

Third Reading Passed (45-0)

upper

Apr 2, 2018

Upper · Passed

Favorable with Amendments {677071/1 Report Adopted

upper

Apr 2, 2018

Upper · Passed

Favorable with Amendments Report by Finance

upper

Feb 15, 2018

Committee

Rereferred to Finance

upper

Feb 12, 2018

Committee

First Reading Senate Rules

upper

1 primary · 2 co-sponsors